IWC
IBB icon

Integrated Wealth Concepts’s iShares Biotechnology ETF IBB Stock Holding History

Integrated Wealth Concepts’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
8,547
-9,348
-52% -$1.61M 0.01% 944
2026
Q1 		$3.02M Sell
17,895
-848
-5% -$145K 0.02% 601
2025
Q4 		$3.16M Buy
18,743
+11,410
+156% +$1.85M 0.04% 415
2025
Q3 		$1.06M Sell
7,333
-549
-7% -$74.9K 0.01% 946
2025
Q2 		$997K Sell
7,882
-304
-4% -$37.3K 0.01% 915
2025
Q1 		$1.05M Sell
8,186
-266
-3% -$36.1K 0.01% 807
2024
Q4 		$1.12M Sell
8,452
-1,868
-18% -$263K 0.01% 767
2024
Q3 		$1.5M Sell
10,320
-507
-5% -$73.4K 0.02% 643
2024
Q2 		$1.49M Buy
10,827
+970
+10% +$129K 0.02% 604
2024
Q1 		$1.35M Buy
9,857
+472
+5% +$64.5K 0.02% 643
2023
Q4 		$1.27M Buy
9,385
+783
+9% +$95.5K 0.02% 631
2023
Q3 		$1.05M Buy
8,602
+502
+6% +$63.8K 0.02% 675
2023
Q2 		$1.03M Buy
8,100
+606
+8% +$78.7K 0.02% 668
2023
Q1 		$968K Buy
7,494
+2,648
+55% +$347K 0.02% 633
2022
Q4 		$636K Sell
4,846
-18,469
-79% -$2.39M 0.02% 583
2022
Q3 		$2.73M Buy
23,315
+17,410
+295% +$2.16M 0.09% 217
2022
Q2 		$695K Sell
5,905
-284
-5% -$33.7K 0.02% 508
2022
Q1 		$806K Sell
6,189
-1,067
-15% -$139K 0.02% 449
2021
Q4 		$1.11M Buy
7,256
+2,069
+40% +$320K 0.03% 388
2021
Q3 		$839K Buy
5,187
+399
+8% +$67.1K 0.03% 444
2021
Q2 		$784K Buy
4,788
+118
+3% +$18.2K 0.03% 419
2021
Q1 		$703K Buy
4,670
+390
+9% +$61.9K 0.03% 383
2020
Q4 		$648K Sell
4,280
-3,417
-44% -$488K 0.03% 353
2020
Q3 		$1.04M Buy
7,697
+2,130
+38% +$289K 0.06% 210
2020
Q2 		$761K Buy
5,567
+3,043
+121% +$388K 0.05% 212
2020
Q1 		$272K Sell
2,524
-2,082
-45% -$240K 0.03% 328
2019
Q4 		$555K Buy
+4,606
New +$514K 0.05% 250

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Integrated Wealth Concepts's IBB Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its iShares Biotechnology ETF (IBB) stake by 52% in Q2 2026, selling an estimated $1.61M and leaving 8,547 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #944.

Integrated Wealth Concepts first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.16M in Q4 2025. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Integrated Wealth Concepts held 8,547 shares of iShares Biotechnology ETF worth $1.63M as of Q2 2026.
  • Integrated Wealth Concepts sold 9,348 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.61M.
  • iShares Biotechnology ETF made up 0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #944 holding.
  • Integrated Wealth Concepts first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Integrated Wealth Concepts's iShares Biotechnology ETF position peaked at $3.16M in Q4 2025.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.